Treatment of ocular infections caused by susceptible microorganisms and prevention of inflammation and
bacterial infection that may occur after ocular surgery.
Dosage & Administration
Prevention of Post-Surgery Ocular Inflammation and Infection: Instill 1 drop, 4 times/day in the eye to be operated, starting 1 day before the surgery and during 15 days after the surgery. Treatment of Ocular Infections Caused by Susceptible Organisms: Instill 1 drop 4 times/day during 7 days, or as directed by the doctor. Patients Submitted to Cataract Surgery: Instil the solution immediately after the surgery. Patients Submitted to Refractive Surgery by LASIK: Instill the solution within 15 minutes after the surgery.
Use in Pregnancy: Pregnancy Category C. The product should be used during pregnancy only if the
potential benefit justifies the potential risk to the fetus as there are no adequate and well-documented
studies in pregnant women.
Use in Lactating Mother: Safety and effectiveness in lactating mother have not
Pediatric Use: Safety and effectiveness in pediatric patients have not been established.
Geriatric Use: No changes of dose are required for elderly patients.
If an allergic reaction to Moxifloxacin occurs, discontinue use of the product and contact with doctor. Prolonged steroid use may result in ocular hypertension and/or glaucoma with damage to the optic nerve, defect in visual acuity and fields of vision, posterior subcapsular cataract formation, or increased hazard of developing secondary ocular infections. The intraocular pressure must be evaluated routinely. In those diseases causing thinning of the cornea or sclera (white part of the eye), perforations have been known to occur with use of topical corticosteroids. In acute purulent conditions of the eye, steroids may mask infection or enhance existing infection.